Targeting the source.
Transforming the outcome.

We develop miRNA-based therapies that address the root causes of neurological diseases. This goes far beyond the limitations of current treatment options, which only manage individual symptoms.

A future where patients with neurological diseases are effectively treated

We are committed to unlocking the full potential of miRNA therapy as a new frontier in the treatment of neurological diseases. With diligence and creativity, we advance promising therapies that harness the power of miRNA biology to effectively treat diseases such as Epilepsy and Parkinson’s.

Building on this commitment, we engage with patients, caregivers and the medical community to ensure we’re working towards outcomes that are truly life changing.

Our Science

Our miRNA-targeting approach restores balance by guiding neural networks back to healthy function.

For Patients

‍Conventional medicine for neurological disease has limitations. By correcting the root causes of disease, our miRNA therapies remedy its diverse impacts for improved patient outcomes.

We share our latest development updates, scientific publications and industry perspectives

24.11.2025

Mads and Morten's Story: Building a Life Around Epilepsy

A father’s perspective on raising a son with severe, drug-resistant epilepsy, and how that journey eventually led him to support Neumirna as an early investor

7.11.2025

More than a Diagnosis: Living with Drug-Resistant Epilepsy

At 11 years old, Emilie experienced her first seizure – a sudden, disorienting moment that marked the beginning of a lifelong condition. What followed was a journey into a world of trial-and-error medication, debilitating side effects and uncertainty that would shape her life through every stage of growing up.